Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2009 048 183.5 |
96 | EP file number | EAKZ | 09 75 1617.3 |
86 | WO file number | WAKZ | PCT/US2009/044918 |
97 | EP publication number | EPN | 2300013 |
87 | WO publication number | WPN | 2009143389 |
54 | Designation/title | TI | PHOSPHOR-DERIVATE ALS KINASE-INHIBITOREN |
51 | IPC main class | ICM (ICMV) | A61K 31/505 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/513 (2006.01) |
22 | DE application date | DAT | May 21, 2009 |
96 | EP application date | EAT | May 21, 2009 |
86 | WO application date | WAT | May 21, 2009 |
43 | Date of first publication | OT | Nov 26, 2009 |
| Date of publication of grant | PET | Sep 6, 2017 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, JP |
72 | Inventor | IN | WANG, Yihan, Newton, MA 02460, US; HUANG, Wei-Sheng, Acton, MA 01720, US; LIU, Shuangying, Wellesley, MA 02481, US; SHAKESPEARE, William, C., Southborough, MA 01772, US; THOMAS, R., Mathew, Sharon, MA 02067, US; QI, Jiwei, West Roxbury, MA 02132, US; LI, Feng, Winchester, MA 01890, US; ZHU, Xiaotian, Newton, MA 02465, US; KOHLMANN, Anna, Winchester, MA 01890, US; DALGARNO, David, C., Brookline, MA 02446, US; ROMERO, Jan, Antoinette, C., Somerville, MA 02144, US; ZOU, Dong, Concord, MA 01742, US |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 192964 P Sep 23, 2008
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 188796 P Aug 13, 2008
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 137490 P Jul 31, 2008
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 128317 P May 21, 2008
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 192938 P Sep 23, 2008
|
| Due date | FT FG | May 31, 2025 Annual fee for the 17th year
Patent fees |
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2019 000 046.1 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | SF - Sonstige Fremdsprache |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | AL, RS, BA |
| Published EP/WO documents | EPWOPN | Original document:
EP000002300013 Searchable text:
EP000002300013 Original document:
EP000002300013B1 Searchable text:
EP000002300013B1 Original document:
EP000002300013B2 Searchable text:
EP000002300013B2 Original document:
WO002009143389 Searchable text:
WO002009143389 |
43 | Date of first publication | EVT | Nov 26, 2009 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 28, 2024 (Show all update days)(Hide all update days)- Nov 28, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 13.11.2024: changed
- Oct 24, 2024
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 13.11.2024: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 13.11.2024: new
- Procedures: Procedure relating to PCT application, Publication of PCT application, 26.11.2009: deleted
- Jun 9, 2024; Apr 26, 2024; Apr 28, 2023; Apr 29, 2022; Oct 28, 2021; Sep 21, 2021; Jun 9, 2021; Jun 5, 2020; Aug 16, 2019; Jun 8, 2019; Nov 13, 2018; Aug 2, 2018; Jun 28, 2018; Jun 14, 2018; Oct 12, 2017; Sep 27, 2017; Sep 7, 2017; May 4, 2017; Jan 5, 2017; Feb 15, 2013
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|